{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:26:06Z","timestamp":1790382366517,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fritz-Thyssen-Foundation","award":["10.15.1.019MN"],"award-info":[{"award-number":["10.15.1.019MN"]}]},{"name":"University of Technology Dresden","award":["60.364"],"award-info":[{"award-number":["60.364"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.clim.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T20:43:29Z","timestamp":1457037809000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Shaping the spectrum \u2014 From autoinflammation to autoimmunity"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-6179","authenticated-orcid":false,"given":"Christian M.","family":"Hedrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.03.002_bb0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2013.03.016","article-title":"Monogenic autoinflammatory diseases: concept and clinical manifestations","volume":"147","author":"Almeida de Jesus","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2009.11.016","article-title":"Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses","volume":"124","author":"Goldbach-Mansky","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clim.2012.12.006","article-title":"Specific inflammasomes in complex diseases","volume":"147","author":"Masters","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00281-015-0497-1","article-title":"Broadening the definition of autoinflammation","volume":"37","author":"Masters","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2016.03.002_bb0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-015-0495-3","article-title":"The autoinflammatory diseases: a fashion with blurred boundaries!","volume":"37","author":"Sarrabay","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2016.03.002_bb0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clim.2013.03.006","article-title":"Bridging the gap between autoinflammation and autoimmunity","volume":"147","author":"Hedrich","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1098\/rspb.2014.3085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proceedings Biological Sciences\/The Royal Society"},{"key":"10.1016\/j.clim.2016.03.002_bb0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","article-title":"Cell type-specific regulation of IL-10 expression in inflammation and disease","volume":"47","author":"Hedrich","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2016.03.002_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clim.2012.02.005","article-title":"Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury","volume":"143","author":"Hofmann","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.clim.2016.03.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00281-015-0493-5","article-title":"New monogenic autoinflammatory diseases\u2014a clinical overview","volume":"37","author":"Canna","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2016.03.002_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00281-015-0478-4","article-title":"Update on genetics and pathogenesis of autoinflammatory diseases: the last 2years","volume":"37","author":"Aksentijevich","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2016.03.002_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030396","article-title":"Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort","volume":"3","author":"Alarcon","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2015.04.018","article-title":"Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches","volume":"159","author":"Bruck","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0090","first-page":"127","article-title":"The systemic autoinflammatory diseases: inborn errors of the innate immune system","volume":"305","author":"Brydges","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0095","first-page":"343","article-title":"Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)","volume":"35","author":"Behrens","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/pr.2013.187","article-title":"Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis","volume":"75","author":"Correll","year":"2014","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clim.2016.03.002_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.03.002_bb0110","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00296-011-2249-4","article-title":"Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"32","author":"Hedrich","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2016.03.002_bb0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0125","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0130","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0135","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0140","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gene.2008.24","article-title":"Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis","volume":"9","author":"Stock","year":"2008","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2016.03.002_bb0150","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.03.002_bb0155","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0160","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar2041","article-title":"Novel IL10 gene family associations with systemic juvenile idiopathic arthritis","volume":"8","author":"Fife","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.03.002_bb0165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1546-0096-11-40","article-title":"Meta-analysis confirms association between TNFA-G238A variant and JIA, and between PTPN22-C1858T variant and oligoarticular, RF-polyarticular and RF-positive polyarticular JIA","volume":"11","author":"Kaalla","year":"2013","journal-title":"Pediatric Rheumatology Online Journal"},{"key":"10.1016\/j.clim.2016.03.002_bb0170","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","article-title":"Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis","volume":"48","author":"De Benedetti","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0175","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5\u2032-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0180","first-page":"912","article-title":"IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"28","author":"Moller","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0185","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.03.002_bb0190","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2016.03.002_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.12631","article-title":"Bimodal immune activation in psoriasis","volume":"170","author":"Christophers","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2016.03.002_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111255","article-title":"CARD14 expression in dermal endothelial cells in psoriasis","volume":"9","author":"Harden","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.03.002_bb0210","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajhg.2012.03.013","article-title":"Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0215","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0220","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1073\/pnas.1518163113","article-title":"Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-kappaB activation and autoinflammatory disease","volume":"113","author":"Zilberman-Rudenko","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.03.002_bb0225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.03.002_bb0235","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/1744666X.2013.824670","article-title":"A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis\/chronic recurrent multifocal osteomyelitis and challenges facing the field","volume":"9","author":"Hedrich","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1546-0096-11-47","article-title":"Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO)","volume":"11","author":"Hedrich","year":"2013","journal-title":"Pediatric Rheumatology Online Journal"},{"key":"10.1016\/j.clim.2016.03.002_bb0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clim.2012.12.012","article-title":"Autoinflammatory bone disorders","volume":"147","author":"Morbach","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0250","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2016.03.002_bb0255","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1038\/ncomms7595","article-title":"Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"6","author":"Lande","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2016.03.002_bb0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","article-title":"Gene-function studies in systemic lupus erythematosus","volume":"9","author":"Crispin","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0265","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clim.2013.01.003","article-title":"Nucleic acid driven sterile inflammation","volume":"147","author":"Ablasser","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncprheum0191","article-title":"Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus","volume":"2","author":"Cook","year":"2006","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"Suppl. 3","key":"10.1016\/j.clim.2016.03.002_bb0280","first-page":"S95","article-title":"Complement deficiency: predisposing factor to autoimmune syndromes","volume":"7","author":"Atkinson","year":"1989","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0285","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000184701","article-title":"Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus","volume":"123","author":"Ptacek","year":"2008","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.clim.2016.03.002_bb0290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Yang","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2016.03.002_bb0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.81","article-title":"Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"International Consortium for Systemic Lupus Erythematosus G","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0305","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","article-title":"Chilblain lupus erythematosus\u2014a review of literature","volume":"27","author":"Hedrich","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0310","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ng.975","article-title":"Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus","volume":"43","author":"Al-Mayouf","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0315","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3\u2032-5\u2032 DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2016.03.002_bb0325","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"167A","author":"Crow","year":"2015","journal-title":"American Journal of Medical Genetics Part A"},{"key":"10.1016\/j.clim.2016.03.002_bb0330","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.03.002_bb0335","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1172\/JCI79100","article-title":"Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations","volume":"124","author":"Jeremiah","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.03.002_bb0340","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000087","article-title":"Advances in understanding the role of type I interferons in systemic lupus erythematosus","volume":"26","author":"Crow","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2016.03.002_bb0350","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.03.002_bb0355","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0961203311425522","article-title":"TLR7\/8\/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil","volume":"21","author":"dos Santos","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2016.03.002_bb0360","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1007\/s11033-014-3447-4","article-title":"Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus","volume":"41","author":"Enevold","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.clim.2016.03.002_bb0365","first-page":"105","article-title":"The TLR7 7926A>G polymorphism is associated with susceptibility to systemic lupus erythematosus","volume":"6","author":"Tian","year":"2012","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.clim.2016.03.002_bb0370","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature04489","article-title":"Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans","volume":"439","author":"Aitman","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.clim.2016.03.002_bb0375","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/08916930701763710","article-title":"Fc receptor genes and the systemic lupus erythematosus diathesis","volume":"40","author":"Brown","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2016.03.002_bb0380","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1182\/blood-2011-12-401133","article-title":"Endocytosis of soluble immune complexes leads to their clearance by FcgammaRIIIB but induces neutrophil extracellular traps via FcgammaRIIA in vivo","volume":"120","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.03.002_bb0385","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ng2046","article-title":"FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity","volume":"39","author":"Fanciulli","year":"2007","journal-title":"Nat. Genet."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T12:25:04Z","timestamp":1536927904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616300298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":77,"alternative-id":["S1521661616300298"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.03.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726198319.793547384","asserted-by":"object"}]},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shaping the spectrum \u2014 From autoinflammation to autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}